By now, these are household names: Mounjaro. Wegovy. Zepbound… and yes, Ozempic. A Kaiser Family Foundation poll found that one in 8 American adults reported trying a GLP-1 medication.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback